ReducingAgentStoichiometryCalculator
Reducing Agent Stoichiometry Calculator
Utility description: Reducing Agent Stoichiometry Calculator
Reducing Agent Stoichiometry Calculator — Calculation of optimal Tin(II) amount for Tc-99m labeling
ℹ️ Utility calculates the optimal volume of Stannous Chloride (SnCl2) solution:
• Based on ligand mass and Tc-99m activity
• Considering excess factor (to compensate for oxidation)
• With checks for toxicity and colloid formation risk
⚠️ CRITICAL: Insufficient tin → low labeling efficiency!
Excess tin → formation of Sn/Tc colloids and liver accumulation!
Calculation helps standardize the kit preparation process.
Usage:
ReducingAgentStoichiometryCalculator.exe → demo mode (console output)
ReducingAgentStoichiometryCalculator.exe input.csv output.json → evaluate your data
Input format:
KitName,LigandMassMg,LigandMolecularWeight,Tc99mActivityGBq,SnCl2ConcentrationMgPerML,ExcessFactor,VolumeToReconstituteML
Example:
Tc99m-MAG3-Kit,1.0,384.4,2.0,1.0,50.0,5.0
— WHY IS THIS NEEDED?
Reduction of Technetium-99m from oxidation state +7 (pertechnetate) to lower states (+4, +5) requires a reducing agent.
Stannous Chloride (SnCl2) is the most common agent.
• Reaction stoichiometry is complex due to rapid oxidation of Sn(II) to Sn(IV) by air oxygen.
• Significant excess of Sn(II) relative to Tc-99m is required (often 1000-10000 times by moles).
• However, excess Sn(II) can lead to formation of colloidal tin hydroxide, which traps Tc-99m, creating an impurity that accumulates in liver and spleen.
• This utility helps find the balance between sufficient amount for labeling and safe levels.
⚠️ CRITICAL:
• Molar ratio Sn/Ligand must be high enough to ensure reaction kinetics.
• Sn concentration in final solution should not exceed toxicity limits (usually < 5 mcg/mL for injections, but locally higher in kits).
• SnCl2 solution must be fresh and protected from oxygen (under nitrogen).
• pH of the medium critically affects Sn(II) stability (more stable in acidic media).
Key features:
• Calculation of Tc-99m atom count based on activity (via decay constant).
• Determination of theoretical minimum tin mass.
• Application of user-defined Excess Factor.
• Colloid formation risk assessment based on final concentration.
• Support for various ligands (MAG3, DTPA, HMPAO, MDP, etc.).
Critical parameters:
• Molar ratio Sn/Ligand: > 1.0 (practically 10-100)
• Final Sn concentration: < 5.0 mg/mL (in reaction zone)
• Volume of added reductant: must be precise (microliters)
💡 Usage tips:
1. Use high-purity SnCl2 dissolved in dilute HCl to prevent hydrolysis.
2. ExcessFactor depends on kit age and vial seal integrity. Increase it for older kits.
3. If calculation shows very small volume (< 1 mkl), consider diluting the initial SnCl2 solution for better dosing accuracy.
4. Always check pH after adding reductant and ligand.
5. For high-activity preparations (> 5 GBq), increasing Sn mass may be required to prevent radiolysis.
⚠️ Note: Tc-99m labeling stoichiometry is not just chemistry, it's a race against time and radiolysis. Correct calculation of tin amount is the key to high radiochemical purity. Calculation errors lead to rejection of the entire batch of expensive isotope.input.csv
KitName,LigandMassMg,LigandMolecularWeight,Tc99mActivityGBq,SnCl2ConcentrationMgPerML,ExcessFactor,VolumeToReconstituteML Tc99m-MAG3-Kit,1.0,384.4,2.0,1.0,50.0,5.0 Tc99m-DTPA-Kit,2.0,393.3,3.0,0.5,100.0,10.0 Tc99m-HMPAO-Kit,0.5,350.0,1.5,2.0,20.0,5.0
URS & FS — user requirements and functional specification
URS — User Requirements Specification
- The utility shall accept
input.csvwith the headers defined by the data contract. - Before calculation, the utility shall detect missing fields, type errors and invalid values.
- The utility shall deterministically perform “Reducing Agent Stoichiometry Calculator”.
- The checks shall include the following criteria: Molar ratio Sn/Ligand: > 1.0 (practically 10-100); Final Sn concentration: < 5.0 mg/mL (in reaction zone); Volume of added reductant: must be precise (microliters).
- Each processed record shall receive a clear PASS, WARNING or FAIL status with the reason.
- The result shall be written to
output.jsonand retain the source values used for the checks. - The result supports batch-data review; release remains with authorised QA/QC personnel.
FS — Functional Specification
- Run
ReducingAgentStoichiometryCalculator.exein demo mode or withinput.csv output.jsonarguments. - Read UTF-8 CSV and validate the header and mandatory columns.
- Convert values to the expected types and validate admissibility.
- Perform the calculation or rule checks for “Reducing Agent Stoichiometry Calculator”.
- Create individual check results and the overall status.
- Write machine-readable JSON; invalid input shall not appear as a successful result.
input.csv example
KitName,LigandMassMg,LigandMolecularWeight,Tc99mActivityGBq,SnCl2ConcentrationMgPerML,ExcessFactor,VolumeToReconstituteML Tc99m-MAG3-Kit,1.0,384.4,2.0,1.0,50.0,5.0
Minimum output.json structure
{
"utility": "ReducingAgentStoichiometryCalculator",
"source": "input.csv",
"status": "PASS|WARNING|FAIL",
"checks": [
{
"parameter": "example",
"status": "PASS",
"message": "criterion satisfied"
}
],
"errors": []
}
Before operational use
- Limits and coefficients shall be approved before operational use.
- After an executable or rule change, repeat the affected tests.
- Retain the source CSV and JSON result together in the controlled process.
Included in packages
Radiopharmaceutical Diagnostics and Therapy QC Suite
36 utilities for clinically oriented radiopharmaceutical and workflow quality control: PET/SPECT tracers, the Tc-99m renal workflow, PRRT, PSMA therapy, targeted alpha therapy, radioembolization, bone-pain palliation, immuno-PET and generator-based radionuclide control.
OpenRPH isotope family: Tc-99m
Tc-99m radiopharmaceuticals, kit preparation, generator control, SPECT workflows and calculation utilities.
OpenRPH organ/system: bone and musculoskeletal
Bone scintigraphy, MDP/PYP, marrow, bone-pain palliation, skeletal metastases and radiosynovectomy.
OpenRPH organ/system: hepatobiliary and GI
HIDA, mebrofenin, gallbladder, gastric emptying, GI transit, bleeding and liver/spleen imaging.
OpenRPH organ/system: renal and urinary
Renography, GFR/ERPF, renal uptake, DMSA/MAG3/DTPA and bladder-related workflows.
OpenRPH Tc-99m Renal Radiopharmaceutical and Imaging QC Suite
16 utilities covering the Tc-99m renal workflow: generator eluate and Mo-99 breakthrough, Sn(II), labeling stoichiometry and pH, radiochemical purity and stability of MAG3, DTPA, DMSA(III) and glucoheptonate, gamma-camera uniformity, renal uptake and plasma clearance, bladder voiding efficiency, patient dosimetry and decay-in-storage waste management.
OpenRPH use case: Tc-99m renal and nephrourology
Renal radiopharmaceuticals and calculation workflows: MAG3, DTPA, DMSA, glucoheptonate, generator Tc-99m, dynamic renography, GFR/ERPF and dosimetry.
OpenRPH workflow: imaging QC and quantitative interpretation
Acquisition, uptake, clearance, perfusion, transit, ejection fraction, segmentation and quantitative imaging.
OpenRPH workflow: product release QC
Assay, purity, sterility, endotoxins, pH, impurities, appearance and batch-release checks.
OpenRPH workflow: stability, storage, decay and waste
Kinetic stability, shelf life, decay correction, expiry, storage, trend and radioactive waste.
OpenRPH workflow: synthesis, labelling and kit reconstitution
Radiolabelling, synthesis, chelation, reducing agent, pH/stoichiometry and kit preparation.
Open